New insights into Whipple's disease and Tropheryma whipplei infections

Microbes and Infection

Volumn 12, Issue 14-15, 2010, Pages 1102-1110

  Desnues, Benoit ^a   Al Moussawi, Khatoun ^a   Fenollar, Florence ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Host pathogen interaction; Tropheryma whipplei; Whipple's disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE; HYDROXYCHLOROQUINE; LEVOFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFADIAZINE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CARRIER; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; GASTROENTERITIS; GENE SEQUENCE; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; INTESTINE LIPODYSTROPHY; MACROPHAGE FUNCTION; MONOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT FAILURE; TREATMENT OUTCOME;

ACTINOMYCETALES INFECTIONS; CARRIER STATE; HUMANS; TROPHERYMA; WHIPPLE DISEASE;

BACTERIA (MICROORGANISMS); TROPHERYMA WHIPPLEI;

EID: 78649861821     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.08.001     Document Type: Short Survey

References (82)

1. Whipple G.H. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull. Johns Hopkins Hosp. 1907, 18:382-391.
2. Yardley J.H., Hendrix T.R. Combined electron microscopy and light microscopy in Whipple's disease: demonstration of "bacillary bodies" in the intestine. Bull. Johns Hopkins Hosp. 1961, 109:80-98.
3. Wilson K.H., Blitchington R., Frothingham R., Wilson J.A. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991, 338:474-475.
4. Raoult D., Birg M.L., La Scola B., Fournier P.E., Enea M., Lepidi H., Roux V., Piette J.C., Vandenesch F., Vital-Durand D., Marrie T.J. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 2000, 342:620-625.
5. Bentley S.D., Maiwald M., Murphy L.D., Pallen M.J., Yeats C.A., Dover L.G., Norbertczak H.T., Besra G.S., Quail M.A., Harris D.E., von Herbay A., Goble A., Rutter S., Squares R., Squares S., Barrell B.G., Parkhill J., Relman D.A. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet 2003, 361:637-644.
6. Raoult D., Ogata H., Audic S., Robert C., Suhre K., Drancourt M., Claverie J.M. Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome. Genome Res. 2003, 13:1800-1809.
7. Renesto P., Crapoulet N., Ogata H., La Scola B., Vestris G., Claverie J.M., Raoult D. Genome-based design of a cell-free culture medium for Tropheryma whipplei. Lancet 2003, 362:447-449.
8. Fenollar F., Laouira S., Lepidi H., Rolain J.M., Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin. Infect. Dis. 2008, 47:659-667.
9. J.C. Lagier, H. Lepidi, D. Raoult, F. Fenollar, Clinical presentation of 142 patients with systemic Tropheryma whipplei infections diagnosed or confirmed in a reference center, Medicine, in press.
10. Rickman L.S., Freeman W.R., Green W.R., Feldman S.T., Sullivan J., Russack V., Relman D.A. Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus). N. Engl. J. Med. 1995, 332:363-366.
11. Bousbia S., Papazian L., Auffray J.P., Fenollar F., Martin C., Li W., Chiche L., La Scola B., Raoult D. Tropheryma whipplei in patients with pneumonia. Emerg. Infect. Dis. 2010, 16:258-263.
12. Raoult D., Fenollar F., Rolain J.M., Minodier P., Bosdure E., Li W., Garnier J.M., Richet H. Tropheryma whipplei in children with gastroenteritis. Emerg. Infect. Dis. 2010, 16:776-782.
13. Fenollar F., Puechal X., Raoult D. Whipple's disease. N. Engl. J. Med. 2007, 356:55-66.
14. Mahnel R., Kalt A., Ring S., Stallmach A., Strober W., Marth T. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am. J. Gastroenterol. 2005, 100:1167-1173.
15. Durand D.V., Lecomte C., Cathebras P., Rousset H., Godeau P. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Medicine (Baltimore) 1997, 76:170-184.
16. Puechal X. Whipple disease and arthritis. Curr. Opin. Rheumatol. 2001, 13:74-79.
17. Fresard A., Guglielminotti C., Berthelot P., Ros A., Farizon F., Dauga C., Rousset H., Lucht F. Prosthetic joint infection caused by Tropheryma whippelii (Whipple's bacillus). Clin. Infect. Dis. 1996, 22:575-576.
18. Dobbins W.O. Whipple's Disease 1987, Charles. C. Thomas, Springfield, Il.
19. Gerard A., Sarrot-Reynauld F., Liozon E., Cathebras P., Besson G., Robin C., Vighetto A., Mosnier J.F., Durieu I., Vital Durand D., Rousset H. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore) 2002, 81:443-457.
20. Louis E.D., Lynch T., Kaufmann P., Fahn S., Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann. Neurol. 1996, 40:561-568.
21. Drancourt M., Raoult D., Lepidi H., Fenollar F., Birg M.L., Bodaghi B., Hoang P.L., Lelievre J.D. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann. Intern. Med. 2003, 139:1046-1047.
22. E. Angelakis, F. Fenollar, H. Lepidi, M.L. Birg, D. Raoult, Tropheryma whipplei in the skin of patients with classic Whipple's disease, J. Infect. 61 (2010) 266-269.
23. Lagier J.C., Fenollar F., Lepidi H., Liozon E., Raoult D. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide. J. Infect. 2010, 60:79-82.
24. Raoult D. A febrile blood culture-negative endocarditis. Ann. Intern. Med. 1999, 131:144-146.
25. Fenollar F., Trani M., Davoust B., Salle B., Birg M.L., Rolain J.M., Raoult D. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J. Infect. Dis. 2008, 197:880-887.
26. Fenollar F., Trape J.F., Bassene H., Sokhna C., Raoult D. Tropheryma whipplei in fecal samples from children, Senegal. Emerg. Infect. Dis. 2009, 15:922-924.
27. Maiwald M., von Herbay A., Persing D.H., Mitchell P.P., Abdelmalek M.F., Thorvilson J.N., Fredricks D.N., Relman D.A. Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease. Ann. Intern. Med. 2001, 134:115-119.
28. Ehrbar H.U., Bauerfeind P., Dutly F., Koelz H.R., Altwegg M. PCR-positive tests for Tropheryma whippelii in patients without Whipple's disease. Lancet 1999, 353:2214.
29. Misbah S.A., Stirzaker D., Ozols B., Franks A., Mapstone N. Anonymous survey of blood donors by polymerase chain reaction for Tropheryma whippelii. Qjm 1999, 92:61.
30. Rolain J.M., Fenollar F., Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007, 7:48.
31. Street S., Donoghue H.D., Neild G.H. Tropheryma whippelii DNA in saliva of healthy people. Lancet 1999, 354:1178-1179.
32. Zinkernagel A.S., Gmur R., Fenner L., Schaffner A., Schoedon G., Schneemann M. Marginal and subgingival plaque-a natural habitat of Tropheryma whipplei?. Infection 2003, 31:86-91.
33. Genot S., Stein A., Lepidi H., Ihrig M., Raoult D., Mege J.L. Murine model of infection by Tropheryma whipplei. Infect. Immun. 2006, 74:4915-4917.
34. Black-Schaffer B. The tinctoral demonstration of a glycoprotein in Whipple's disease. Proc. Soc. Exp. Biol. Med. 1949, 72:225-227.
35. Fleming J.L., Wiesner R.H., Shorter R.G. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin. Proc. 1988, 63:539-551.
36. Schneider T., Moos V., Loddenkemper C., Marth T., Fenollar F., Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect. Dis. 2008, 8:179-190.
37. Roth R.I., Owen R.L., Keren D.F., Volberding P.A. Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease. Dig. Dis. Sci. 1985, 30:497-504.
38. Strom R.L., Gruninger R.P. AIDS with Mycobacterium avium-intracellulare lesions resembling those of Whipple's disease. N. Engl. J. Med. 1983, 309:1323-1325.
39. Baisden B.L., Lepidi H., Raoult D., Argani P., Yardley J.H., Dumler J.S. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am. J. Clin. Pathol. 2002, 118:742-748.
40. Fenollar F., Raoult D. Molecular techniques in Whipple's disease. Expert Rev. Mol. Diagn. 2001, 1:299-309.
41. Fenollar F., Fournier P.E., Robert C., Raoult D. Use of genome selected repeated sequences increases the sensitivity of PCR detection of Tropheryma whipplei. J. Clin. Microbiol. 2004, 42:401-403.
42. Raoult D., Fenollar F., Birg M.L. Culture of T. whipplei from the stool of a patient with Whipple's disease. N. Engl. J. Med. 2006, 355:1503-1505.
43. Bonhomme C.J., Renesto P., Nandi S., Lynn A.M., Raoult D. Serological microarray for a paradoxical diagnostic of Whipple's disease. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:959-968.
44. Bonhomme C.J., Renesto P., Desnues B., Ghigo E., Lepidi H., Fourquet P., Fenollar F., Henrissat B., Mege J.L., Raoult D. Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease. J. Infect. Dis. 2009, 199:1043-1052.
45. Fenollar F., Amphoux B., Raoult D. A paradoxical Tropheryma whipplei western blot differentiates patients with Whipple disease from asymptomatic carriers. Clin. Infect. Dis. 2009, 49:717-723.
46. Keinath R.D., Merrell D.E., Vlietstra R., Dobbins W.O. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology 1985, 88:1867-1873.
47. Schnider P.J., Reisinger E.C., Gerschlager W., Muller C., Berger T., Krejs G.J., Auff E. Long-term follow-up in cerebral Whipple's disease. Eur. J. Gastroenterol. Hepatol. 1996, 8:899-903.
48. Boulos A., Rolain J.M., Mallet M.N., Raoult D. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J. Antimicrob. Chemother. 2005, 55:178-181.
49. Boulos A., Rolain J.M., Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob. Agents Chemother. 2004, 48:747-752.
50. Fenollar F., Rolain J.M., Alric L., Papo T., Chauveheid M.P., van de Beek D., Raoult D. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int. J. Antimicrob. Agents 2009, 34:255-259.
51. Ghigo E., Capo C., Aurouze M., Tung C.H., Gorvel J.P., Raoult D., Mege J.L. Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infect. Immun. 2002, 70:1501-1506.
52. Lagier J.C., Fenollar F., Halle O., Lepidi H., Raoult D. Efficacy of antibiotic therapy in polyarthritis: a clue suggesting Whipple's disease. Int. J. Antimicrob. Agents 2009, 34:389-390.
53. Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010, 138:478-486. quiz 411-472.
54. Fenollar F., Raoult D. Infection: how should classic Whipple disease be managed?. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:246-248.
55. Marth T. New insights into Whipple's disease - a rare intestinal inflammatory disorder. Dig. Dis. 2009, 27:494-501.
56. Maiwald M., Ditton H.J., von Herbay A., Rainey F.A., Stackebrandt E. Reassessment of the phylogenetic position of the bacterium associated with Whipple's disease and determination of the 16S-23S ribosomal intergenic spacer sequence. Int. J. Syst. Bacteriol. 1996, 46:1078-1082.
57. Maiwald M., Schuhmacher F., Ditton H.J., von Herbay A. Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Appl. Environ. Microbiol. 1998, 64:760-762.
58. Schoniger-Hekele M., Petermann D., Weber B., Muller C. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl. Environ. Microbiol. 2007, 73:2033-2035.
59. Schoedon G., Goldenberger D., Forrer R., Gunz A., Dutly F., Hochli M., Altwegg M., Schaffner A. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J. Infect. Dis. 1997, 176:672-677.
60. Feurle G.E., Dorken B., Schopf E., Lenhard V. HLA B27 and defects in the T-cell system in Whipple's disease. Eur. J. Clin. Invest. 1979, 9:385-389.
61. Martinetti M., Biagi F., Badulli C., Feurle G.E., Muller C., Moos V., Schneider T., Marth T., Marchese A., Trotta L., Sachetto S., Pasi A., De Silvestri A., Salvaneschi L., Corazza G.R. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 2009, 136:2289-2294.
62. Stoll T., Keusch G., Jost R., Burger H., Oelz O. IgA nephropathy and hypercalcemia in Whipple's disease. Nephron 1993, 63:222-225.
63. Marth T., Kleen N., Stallmach A., Ring S., Aziz S., Schmidt C., Strober W., Zeitz M., Schneider T. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 2002, 123:1468-1477.
64. Marth T., Roux M., von Herbay A., Meuer S.C., Feurle G.E. Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin. Immunol. Immunopathol 1994, 72:217-226.
65. Bjerknes R., Laerum O.D., Odegaard S. Impaired bacterial degradation by monocytes and macrophages from a patient with treated Whipple's disease. Gastroenterology 1985, 89:1139-1146.
66. Bai J.C., Sen L., Diez R., Niveloni S., Maurino E.C., Estevez M.E., Boerr L.A. Impaired monocyte function in patients successfully treated for Whipple's disease. Acta Gastroenterol. Latinoam. 1996, 26:85-89.
67. Marth T., Neurath M., Cuccherini B.A., Strober W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997, 113:442-448.
68. Schneider T., Stallmach A., von Herbay A., Marth T., Strober W., Zeitz M. Treatment of refractory Whipple disease with interferon-gamma. Ann. Intern. Med. 1998, 129:875-877.
69. Desnues B., Lepidi H., Raoult D., Mege J.L. Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J. Infect. Dis. 2005, 192:1642-1646.
70. Benoit M., Desnues B., Mege J.L. Macrophage polarization in bacterial infections. J. Immunol. 2008, 181:3733-3739.
71. Moos V., Schmidt C., Geelhaar A., Kunkel D., Allers K., Schinnerling K., Loddenkemper C., Fenollar F., Moter A., Raoult D., Ignatius R., Schneider T. Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 2010, 138:210-220.
72. Moos V., Kunkel D., Marth T., Feurle G.E., LaScola B., Ignatius R., Zeitz M., Schneider T. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease. J. Immunol. 2006, 177:2015-2022.
73. Fenollar F., Lepidi H., Gerolami R., Drancourt M., Raoult D. Whipple disease associated with Giardiasis. J. Infect. Dis. 2003, 188:828-834.
74. Desnues B., Raoult D., Mege J.L. IL-16 is critical for Tropheryma whipplei replication in Whipple's disease. J. Immunol. 2005, 175:4575-4582.
75. Al Moussawi K., Ghigo E., Kalinke U., Alexopoulou L., Mege J.L., Desnues B. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog. 2010, 6:e1000722.
76. Desnues B., Ihrig M., Raoult D., Mege J.L. Whipple's disease: a macrophage disease. Clin. Vaccine Immunol. 2006, 13:170-178.
77. Gorvel L., Al Moussawi K., Ghigo E., Capo C., Mege J.L., Desnues B. Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway. Cell Death Dis. 2010, 1:e34.
78. Zhang Y., Center D.M., Wu D.M., Cruikshank W.W., Yuan J., Andrews D.W., Kornfeld H. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 1998, 273:1144-1149.
79. Benoit M., Fenollar F., Raoult D., Mege J.L. Increased levels of circulating IL-16 and apoptosis markers are related to the activity of Whipple's disease. PloS One 2007, 2:e494.
80. Haimovich B., Venkatesan M.M. Shigella and Salmonella: death as a means of survival. Microbes Infect. 2006, 8:568-577.
81. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
82. Trakala M., Arias C.F., Garcia M.I., Moreno-Ortiz M.C., Tsilingiri K., Fernandez P.J., Mellado M., Diaz-Meco M.T., Moscat J., Serrano M., Martinez A.C., Balomenos D. Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1). Eur. J. Immunol. 2009, 39:810-819.